PubMed Health⌕ Search

PubMed · 15367217

Donor kidney exchanges.

Abstract

Kidney transplantation from live donors achieves an excellent outcome regardless of human leukocyte antigen (HLA) mismatch. This development has expanded the opportunity of kidney transplantation from unrelated live donors. Nevertheless, the hazard of hyperacute rejection has usually precluded the transplantation of a kidney from a live donor to a potential recipient who is incompatible by ABO blood type or HLA antibody crossmatch reactivity. Region 1 of the United Network for Organ Sharing (UNOS) has devised an alternative system of kidney transplantation that would enable either a simultaneous exchange between live donors (a paired exchange), or a live donor/deceased donor exchange to incompatible recipients who are waiting on the list (a live donor/list exchange). This Regional system of exchange has derived the benefit of live donation, avoided the risk of ABO or crossmatch incompatibility, and yielded an additional donor source for patients awaiting a deceased donor kidney. Despite the initial disadvantage to the list of patients awaiting an O blood type kidney, as every paired exchange transplant removes a patient from the waiting list, it also avoids the incompatible recipient from eventually having to go on the list. Thus, this approach also increases access to deceased donor kidneys for the remaining candidates on the list.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Francis L Delmonico, Paul E Morrissey, George S Lipkowitz, Jeffrey S Stoff, Jonathan Himmelfarb, William Harmon, Martha Pavlakis, Helen Mah, Jane Goguen, Richard Luskin, Edgar Milford, Giacomo Basadonna, Michael Chobanian, Beth Bouthot, Marc Lorber, Richard J Rohrer. 2004. Donor kidney exchanges.. https://doi.org/10.1111/j.1600-6143.2004.00572.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia.

A population-based cohort study of recipients of organs from donors with a recognized history or active cancer has been conducted by linking the Italian National Registry of Transplanted Patients and the National Registry of Donors with Neoplasia Risk. Between 2002 and 2004, 8,198 solid organ transplants have been performed in Italy, 108 of them with organs from 59 cadaveric donors with various risk of neoplasia. There were two reported cases of nonmelanoma skin cancer during the follow up of the transplanted patients, which lasted 27.6+/-11.3 months (234 patient-years). In our study, recipients of organs from donors with various degree of neoplasia risk are exposed to a low risk of cancer transmission.

Cadaver↗

[Primary stability of the capsule-labrum complex after reconstruction with the Mitek Bioknotless anchor system in human cadaver models].

BACKGROUND: This study examines the postoperative stability of the Mitek Bioknotless anchor system with biomechanical draw-out pulling in human cadaver shoulders. METHOD: With simulation of anterior shoulder dislocation a test group (n=10, Ø 45 years) was tested against a native group (n=8, Ø 47 years). All shoulders were dissected up to the passive stabilizers. In the test group an artificial Bankart lesion was created and repaired with three Mitek Bioknotless anchors. The humeri of both groups were fixed in 60 degrees glenohumeral abduction and 90 degrees external rotation and then dislocated in a ventral direction. For evaluation purposes the ultimate draw-out strength, mode of failure, translation of humeral head, capsular slope, and bone density in the test group were measured. RESULTS: In the test group the ultimate strength was a median of 937 N (min. 554 N, max. 1,294 N) with 28 bony anchor dislocations, 1 suture rupture, and 1 capsular rupture, and in the native group with 6 Bankart and 2 HAGL lesions it was 1,214 N (708 N, 1,471 N). The bone density showed a positive correlation to the draw-out strength regarding cortical density and total density. CONCLUSION: Regarding the high draw-out strength the Mitek Bioknotless anchor system provides enough stability for early functional treatment.

Cadaver↗